Logo-bi
Original Research
Hassan Namazi*, Sanaz Motamedi, Mina Namvari
Bioimpacts. 2011;1(1): 63-69. doi: 10.5681/bi.2011.009
PMCID: PMC3648942     PMID: 23678409     Scopus ID: 84876698090    
PDF
XML
Cited By:
Original Research
Hassan Namazi*, Yousef Toomari, Hassan Abbaspour
Bioimpacts. 2014;4(4): 175-182. doi: 10.15171/bi.2014.010
PMCID: PMC4298708     PMID: 25671173     Scopus ID: 84921000950    
PDF
XML
Cited By:
Editorial
Hassan Namazi*
Bioimpacts. 2017;7(2): 73-74. doi: 10.15171/bi.2017.09
PMCID: PMC5524987     PMID: 28752070     Scopus ID: 85027469366    
Original Research
Hassan Namazi*, Elnaz Abdollahzadeh
Bioimpacts. 2018;8(2): 99-106. doi: 10.15171/bi.2018.12
PMCID: PMC6026521     PMID: 29977831     Scopus ID: 85048075763    
Original Research
Zahra Karimzadeh, Siamak Javanbakht, Hassan Namazi*
Bioimpacts. 2019;9(1): 5-13. doi: 10.15171/bi.2019.02
PMCID: PMC6378098     PMID: 30788255     Scopus ID: 85060437287    
Carboxymethylcellulose/MOF-5/Graphene oxide bio-nanocomposite was synthesized through a solvothermal technique, which it could encapsulate tetracycline. The drug release tests showed the stability of drug dosing in the gastrointestinal tract conditions. Antibacterial tests exhibited suitable activity to negatively charge E. coli bacteria.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge